A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design.

Source:http://linkedlifedata.com/resource/pubmed/id/17440642

Download in:

View as

General Info

PMID
17440642